Risk factors for colonization with extended-spectrum cephalosporin-resistant and carbapenem-resistant Enterobacterales among hospitalized patients in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) study

• Published in: IJID regions 2024-06, Vol.11, p.100361-100361, Article 100361
• Main Authors: Caudell, Mark A., Castillo, Carmen, Santos, Lucas F., Grajeda, Laura, Romero, Juan Carlos, Lopez, Maria Renee, Omulo, Sylvia, Ning, Mariangeli Freitas, Palmer, Guy H., Call, Douglas R., Cordon-Rosales, Celia, Smith, Rachel M., Herzig, Carolyn T.A., Styczynski, Ashley, Ramay, Brooke M.
• Format: Article
• Language: English
• Subjects: Antimicrobial resistance; Colonization; Guatemala; Hospitals; Original Report
• ISSN: 2772-7076; 2772-7076
• DOI: 10.1016/j.ijregi.2024.100361

•Among inpatients, human colonization with cephalosporin- and carbapenem-resistant bacteria was high.•Cephalosporin and carbapenem administration were predictive of colonization.•Length of stay, previous hospitalization, and intubation were also predictive.•No household-level variables predicted colonization in the hospital.•Colonization may serve as a useful metric to assess infection prevention and control programs in hospitals. The spread of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) has resulted in increased morbidity, mortality, and health care costs worldwide. To identify the factors associated with ESCrE and CRE colonization within hospitals, we enrolled hospitalized patients at a regional hospital located in Guatemala. Stool samples were collected from randomly selected patients using a cross-sectional study design (March-September, 2021), and samples were tested for the presence of ESCrE and CRE. Hospital-based and household variables were examined for associations with ESCrE and CRE colonization using lasso regression models, clustered by ward (n = 21). A total of 641 patients were enrolled, of whom complete data sets were available for 593. Colonization with ESCrE (72.3%, n = 429/593) was negatively associated with carbapenem administration (odds ratio [OR] 0.21, 95% confidence interval [CI] 0.11-0.42) and positively associated with ceftriaxone administration (OR 1.61, 95% CI 1.02-2.53), as was reported hospital admission within 30 days of the current hospitalization (OR 2.84, 95% CI 1.19-6.80). Colonization with CRE (34.6%, n = 205 of 593) was associated with carbapenem administration (OR 2.62, 95% CI 1.39-4.97), reported previous hospital admission within 30 days of current hospitalization (OR 2.58, 95% CI 1.17-5.72), hospitalization in wards with more patients (OR 1.05, 95% CI 1.02-1.08), hospitalization for ≥4 days (OR 3.07, 95% CI 1.72-5.46), and intubation (OR 2.51, 95% CI 1.13-5.59). No household-based variables were associated with ESCrE or CRE colonization in hospitalized patients. The hospital-based risk factors identified in this study are similar to what has been reported for risk of health care–associated infections, consistent with colonization being driven by hospital settings rather than community factors. This also suggests that colonization with ESCrE and CRE could be a useful metric to evaluate the efficacy of infection and prevention control programs in c